Immix Biopharma (IMMX) Enterprise Value (2020 - 2026)
Immix Biopharma (IMMX) reported Enterprise Value of -$90.6 million for Q1 2026, down 468.93% on a YoY basis from $24.6 million in Q1 2025, and up 9.81% sequentially from -$100.4 million in Q4 2025.
Immix Biopharma (IMMX) Enterprise Value (2020 - 2026) Analysis & Trends
Immix Biopharma (IMMX) has 7 years of Enterprise Value data on file, last reported at -$90.6 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 468.93% year-over-year to -$90.6 million; the trailing twelve-month figure through Mar 2026 stood at -$90.6 million (down 468.93% YoY), and the FY2025 full-year result was -$100.4 million, down 467.97% from the prior year.
- Enterprise Value climbed to -$90.6 million in Q1 2026, from -$100.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$11.5 million in Q1 2023 to a low of -$100.4 million in Q4 2025.
- A 5-year average of -$26.8 million and a median of -$17.7 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 51.62% in 2025 and sank 468.93% in 2026, its largest moves.
- Tracing IMMX's Enterprise Value over 5 years: stood at -$13.4 million in 2022, then sank by 31.81% to -$17.7 million in 2023, then gained by 0.17% to -$17.7 million in 2024, then tumbled by 467.97% to -$100.4 million in 2025, then advanced by 9.81% to -$90.6 million in 2026.
- Business Quant data shows IMMX's Enterprise Value at -$90.6 million in Q1 2026, -$100.4 million in Q4 2025, and -$15.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Immix Biopharma | 487.25 Mn | 487.25 Mn | - | -90.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -90.58 Mn |
| Dec 31, 2025 | -100.43 Mn |
| Sep 30, 2025 | -15.95 Mn |
| Jun 30, 2025 | -11.60 Mn |
| Mar 31, 2025 | -15.92 Mn |
| Dec 31, 2024 | -17.68 Mn |
| Sep 30, 2024 | -19.69 Mn |
| Jun 30, 2024 | -23.98 Mn |
| Mar 31, 2024 | -29.60 Mn |
| Dec 31, 2023 | -17.71 Mn |
| Sep 30, 2023 | -19.71 Mn |
| Jun 30, 2023 | -12.71 Mn |
| Mar 31, 2023 | -11.50 Mn |
| Dec 31, 2022 | -13.44 Mn |
| Sep 30, 2022 | -16.92 Mn |
| Jun 30, 2022 | -18.40 Mn |
| Mar 31, 2022 | -19.06 Mn |
| Dec 31, 2021 | -17.64 Mn |
| Dec 31, 2020 | -391,086.00 |